Editorial: understanding IBS pathophysiology through "converging channels" of research-authors' reply
Aliment Pharmacol Ther
.
2021 Nov;54(9):1215-1216.
doi: 10.1111/apt.16613.
Authors
Madhusudan Grover
1
,
Antonio Berumen
1
,
Stephanie Peters
1
,
Ting Wei
2
,
Margaret Breen-Lyles
1
,
William S Harmsen
3
,
Irene Busciglio
1
,
Duane Burton
1
,
Maria Vazquez Roque
4
,
Kenneth R DeVault
4
,
Michael Camilleri
1
,
Michael Wallace
4
,
Surendra Dasari
2
,
Helmut Neumann
5
6
,
Lesley A Houghton
4
7
Affiliations
1
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
2
Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
3
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
4
Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
5
Department of Medicine I, University Medical Center, Mainz, Germany.
6
GastroZentrum Lippe, Bad Salzuflen, Germany.
7
Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
PMID:
34637534
DOI:
10.1111/apt.16613
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Irritable Bowel Syndrome*